Fundraising Fox

Alnylam

4 known investors

alnylam.com ↗

Alnylam is a biopharmaceutical company that supports investigator-initiated studies in therapeutic areas including transthyretin-mediated amyloidosis, acute hepatic porphyria, and primary hyperoxaluria for medical researchers and healthcare professionals.

BiotechDigital HealthMedical Devicesin /alnylam-pharmaceuticals@alnylam

Investors · 4

ARCH Venture PartnersChicago · $50K – $250M
Atlas VentureCambridge · $500K – $1M
Blackstone Life SciencesNew York · $20M – $60M
Cardinal PartnersPrinceton

In the news